Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations [Phase 2, Phase 3]
The DETERMINE trial update investigates the combination of Trastuzumab and Pertuzumab for HER2-amplified or activating-mutant cancers in adu…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial [Phase 2]
The FUTURE trial (Phase 2) investigates using FAPI PET imaging together with liquid biopsy to stage and guide management of bladder cancer. …
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
Clinical trial update reporting ctDNA findings in patients with muscle-invasive bladder cancer treated with trimodality therapy.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
This clinical trial completed development of a multiphasic CT-based delta-radiomics model to predict postoperative recurrence risk in bladde…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) [NA]
Clinical trial update indicates Medtronic's Hugo Robotic Assisted Surgery System is being evaluated in urologic surgeries across several con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?
A recruiting clinical trial in women with isolated acute cystitis and macroscopic hematuria to evaluate the need for further investigation o…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients [NA]
A clinical trial update describing Hyperthermic Intravesical Chemotherapy (HIVEC) for high-grade non-muscle invasive bladder cancer that is …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers [NA]
A recruiting clinical trial evaluating whether late 18F-FDG PET-CT imaging improves assessment of tumor extensions in muscle-invasive bladde…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy [NA]
Clinical trial entry from Johns Hopkins University recruiting to study home intravenous fluid infusion after radical cystectomy for bladder …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy [Phase 2]
Phase 2 study of atezolizumab after chemo-radiotherapy for muscle-invasive bladder cancer patients who are not eligible for radical cystecto…
-
CLINICAL_TRIALS other · 2025-11-18Clinical Trial Update: (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer [EARLY_Phase 1]
An early-phase clinical trial named CLONEVO is investigating cell cycle inhibition to target urothelial (bladder) cancer; the study is activ…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Multiparametric Magnetic Resonance Imaging (MRI) to Improve Bladder Cancer Staging and Treatment Decision-making [NA]
Completed clinical trial evaluating multiparametric MRI to improve bladder cancer staging and guide treatment decisions.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy [NA]
This clinical trial update describes ongoing recruitment for evaluating the safety and efficacy of a prostate-sparing radical cystectomy. Th…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma [Phase 2]
This is a Phase 2 clinical trial from Rutgers evaluating sequential gemcitabine and mitomycin for favorable high‑risk upper tract urothelial…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Longitudinal Bladder Cancer Study for Tumour Recurrence
A recruiting longitudinal study evaluating biomarker testing for monitoring tumour recurrence in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)] [Phase 2]
This clinical trial update describes a Phase 2 study evaluating pembrolizumab plus Bacillus Calmette-Guérin as first-line therapy for high-r…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy [NA]
Clinical trial update on using remote monitoring to improve patient-reported outcomes and reduce readmission after radical cystectomy for bl…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
Results from the CISTO trial compare intravesical therapy with surgical options as treatments for bladder cancer. The study includes non-mus…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Sacituzumab Govitecan Plus EV in Metastatic UC [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating sacituzumab govitecan in combination with Enfortumab Vedotin for metastatic urothelial cancer; the …
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Avelumab and Radiation in Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating avelumab with radiation for muscle-invasive bladder cancer was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
Clinical trial INSITE investigates pre-surgical identification of muscle-invasive tumor involvement in patients with urothelial carcinoma sc…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy [Phase 1]
A Phase 1 trial evaluating NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy for patients with advanced cancers; the st…
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial [Phase 2]
The NERA trial, a Phase 2 study of erdafitinib with or without atezolizumab in localized bladder cancer patients ineligible for cisplatin ch…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer [NA]
A Phase II trial evaluating an organ-conserving radiochemotherapy approach for muscle-invasive bladder cancer has been terminated, with resu…